Siyata Mobile, Inc. engages in the provision of cellular communications systems for enterprise customers. It specializes in connected vehicle products for professional fleets, marketed under the Uniden Cellular and Siyata brands. The firm operates through the following geographical segments: Europe, the Middle East and Africa; Unites States; Canada; and Australia and New Zealand. The company was founded by Marc Seelenfreund on October 15, 1986 and is headquartered in Montreal, Canada.

Wheeler Real Estate Investment Trust, Inc. engages in the acquisition, finance, development, lease, ownership, and management of retail properties. Its property portfolio includes income producing, strip centers, neighborhood, grocery-anchored, community, and free-standing retail properties. The company was founded on June 23, 2011 and is headquartered in Virginia Beach, VA.

Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. Its current development programs focus on the treatment of rare diseases in structural and connective tissues and rare hepatology, gastrointestinal, and metabolic disorders. The company was founded by Jesse Shefferman and Jacqueline Zummo in March 2006 and is headquartered in New York, NY.

DXC Technology Co. engages in the provision of technology consulting, outsourcing and support services. It operates through the Global Business Services (GBS) and Global Infrastructure Services (GIS) segments. The GBS segment provides technology solutions that help clients address challenges and accelerate the digital transformations that are tailored to each client's specific objectives. The GIS segment offers a portfolio of technology offerings that deliver predictable outcomes and measurable results while reducing business risk and operational costs for customers. The company was founded in 1959 and is headquartered in Ashburn, VA.

ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

Mingteng International Corp., Inc. is a holding company, which engages in mold production, repair, and machining activities through its subsidiaries. It provides casting molds for turbocharger systems, braking systems, steering and differential system, and other automotive system parts. The company was founded by Ying Kai Xu on September 20, 2021 and is headquartered in Wuxi, China.

Bruush Oral Care, Inc. operates as an e-commerce business focused on the oral care industry. The firm provides an electric toothbrush via a subscription model. The company was founded by Aneil Singh Manhas and Charles Andrew Green on October 10, 2017 and is headquartered in Toronto, Canada.

Allego NV engages in the provision of charging solutions for electric cars, motors, buses, and trucks, for consumers, businesses, and cities. It offers a range of EV-related services including site design and technical layout, authorization and billing, and operations and maintenance to customers, such as fleets and corporations, charging hosts, original equipment manufacturers, and municipalities. The company was founded on June 3, 2021 and is headquartered in Arnhem, the Netherlands.

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.